US 
array(52) {
  ["SERVER_SOFTWARE"]=>
  string(6) "Apache"
  ["REQUEST_URI"]=>
  string(27) "/product/extracta-dna-prep/"
  ["PATH"]=>
  string(49) "/usr/local/sbin:/usr/local/bin:/usr/sbin:/usr/bin"
  ["PP_CUSTOM_PHP_INI"]=>
  string(48) "/var/www/vhosts/system/quantabio.com/etc/php.ini"
  ["PP_CUSTOM_PHP_CGI_INDEX"]=>
  string(19) "plesk-php74-fastcgi"
  ["SCRIPT_NAME"]=>
  string(10) "/index.php"
  ["QUERY_STRING"]=>
  string(0) ""
  ["REQUEST_METHOD"]=>
  string(3) "GET"
  ["SERVER_PROTOCOL"]=>
  string(8) "HTTP/1.1"
  ["GATEWAY_INTERFACE"]=>
  string(7) "CGI/1.1"
  ["REDIRECT_URL"]=>
  string(27) "/product/extracta-dna-prep/"
  ["REMOTE_PORT"]=>
  string(5) "33902"
  ["SCRIPT_FILENAME"]=>
  string(48) "/var/www/vhosts/quantabio.com/httpdocs/index.php"
  ["SERVER_ADMIN"]=>
  string(14) "root@localhost"
  ["CONTEXT_DOCUMENT_ROOT"]=>
  string(38) "/var/www/vhosts/quantabio.com/httpdocs"
  ["CONTEXT_PREFIX"]=>
  string(0) ""
  ["REQUEST_SCHEME"]=>
  string(5) "https"
  ["DOCUMENT_ROOT"]=>
  string(38) "/var/www/vhosts/quantabio.com/httpdocs"
  ["REMOTE_ADDR"]=>
  string(10) "3.239.6.58"
  ["SERVER_PORT"]=>
  string(3) "443"
  ["SERVER_ADDR"]=>
  string(13) "172.31.63.191"
  ["SERVER_NAME"]=>
  string(17) "www.quantabio.com"
  ["SERVER_SIGNATURE"]=>
  string(0) ""
  ["HTTP_HOST"]=>
  string(17) "www.quantabio.com"
  ["HTTP_X_REAL_IP"]=>
  string(13) "185.93.229.32"
  ["HTTP_X_FORWARDED_FOR"]=>
  string(10) "3.239.6.58"
  ["HTTP_CONNECTION"]=>
  string(5) "close"
  ["HTTP_X_FORWARDED_PROTO"]=>
  string(5) "https"
  ["HTTP_X_SUCURI_CLIENTIP"]=>
  string(10) "3.239.6.58"
  ["HTTP_X_SUCURI_COUNTRY"]=>
  string(2) "US"
  ["HTTP_USER_AGENT"]=>
  string(40) "CCBot/2.0 (https://commoncrawl.org/faq/)"
  ["HTTP_ACCEPT"]=>
  string(63) "text/html,application/xhtml+xml,application/xml;q=0.9,*/*;q=0.8"
  ["HTTP_ACCEPT_LANGUAGE"]=>
  string(14) "en-US,en;q=0.5"
  ["HTTP_ACCEPT_ENCODING"]=>
  string(7) "br,gzip"
  ["SSL_TLS_SNI"]=>
  string(17) "www.quantabio.com"
  ["HTTPS"]=>
  string(2) "on"
  ["HTTP_AUTHORIZATION"]=>
  string(0) ""
  ["SCRIPT_URI"]=>
  string(52) "https://www.quantabio.com/product/extracta-dna-prep/"
  ["SCRIPT_URL"]=>
  string(27) "/product/extracta-dna-prep/"
  ["UNIQUE_ID"]=>
  string(27) "ZCe4bQMI2wHPhDLpK5JUtgAAABE"
  ["REDIRECT_STATUS"]=>
  string(3) "200"
  ["REDIRECT_SSL_TLS_SNI"]=>
  string(17) "www.quantabio.com"
  ["REDIRECT_HTTPS"]=>
  string(2) "on"
  ["REDIRECT_HTTP_AUTHORIZATION"]=>
  string(0) ""
  ["REDIRECT_SCRIPT_URI"]=>
  string(52) "https://www.quantabio.com/product/extracta-dna-prep/"
  ["REDIRECT_SCRIPT_URL"]=>
  string(27) "/product/extracta-dna-prep/"
  ["REDIRECT_UNIQUE_ID"]=>
  string(27) "ZCe4bQMI2wHPhDLpK5JUtgAAABE"
  ["FCGI_ROLE"]=>
  string(9) "RESPONDER"
  ["PHP_SELF"]=>
  string(10) "/index.php"
  ["REQUEST_TIME_FLOAT"]=>
  float(1680324717.8038)
  ["REQUEST_TIME"]=>
  int(1680324717)
  ["SUCURIREAL_REMOTE_ADDR"]=>
  string(13) "185.93.229.32"
}

Extracta DNA Prep for PCR

Quick and easy DNA extraction of PCR-ready genomic DNA
Features & Benefits
  • Simple, reagent-based system requires minimal technical skill
  • Incubation step can be carried out in 96-well PCR plates or tubes using a standard DNA thermal cycler
  • Compatible with a wide-range of clinical specimens, plant and animal tissues, and environmental samples
  • Optional stabilization buffer allows for extended storage of extracted DNA templates

 

Extracta DNA Prep for PCR is intended for molecular biology applications. This product is not intended for the diagnosis, prevention or treatment of a disease.

Product
Kit Size
Order Info
Product
Kit Size
Order Info
Extracta DNA Prep for PCR
Request Sample
Kit Size:
Order Info:
2.5 mL
Order (95091-002)
25 mL
Order (95091-025)
250 mL
Order (95091-250)

Description

Extracta DNA Prep for PCR is a two-component reagent kit for rapid extraction of PCR-ready genomic DNA from a variety of tissues. Samples are processed in less than 30 minutes with minimal hands-on time and technical skill. Extracted genomic DNA is suitable for sensitive downstream PCR applications including end-point PCR, High Resolution Melt Analysis (HRM) and quantitative real-time PCR (qPCR) without requiring any additional clean-up. In addition, the extracted DNA may be
used in multiplexed PCR applications such as transgene or knock-out analyses. Tissue extractions can be done in tubes, plates or deep-well blocks to allow for adaptation to workflow and automation on liquid-handling workstations.

Details

Details

Contents
  • Extraction Reagent (1 x 25 mL or 2 x 125 mL)
  • Stabilization Buffer (1 x 25 mL or 2 x 125 mL)
Performance Data

Performance Data

Comparison of Extract Yield: Mouse Tails
Comparison of Extract Yield: Mouse Ears
Protocol Speed
Multiplex Genotyping
Resource Panel
Customer Testimonials

Customer Testimonials

Extracta DNA Prep for PCR

"I needed to extract DNA from fungal tissue for one of our teaching labs. It worked amazing for further PCR reactions."

 

 

 

Andres P. | University Lab Coordinator
Extracta DNA Prep for PCR - Tissue

"Extracta DNA Prep for PCR  is one of the best, fastest and easiest to use reagent for genomic DNA isolation from human cells."

Scientist | Deutsches Krebsforschungszentrum (DKFZ)
Related Products
Product
Kit Size
Order Info
qScript cDNA SuperMix
Request Sample
Kit Size:
Order Info:
25 x 20 μL rxns (1 x 100 µL)
Order (95048-025)
100 x 20 μL rxns (1 x 400 µL)
Order (95048-100)
500 x 20 μL rxns (2 x 1000 µL)
Order (95048-500)
Product
Kit Size
Order Info
qScript cDNA Synthesis Kit
Request Sample
Kit Size:
Order Info:
25 x 20 μL rxns (1 x 25 µL)
Order (95047-025)
100 x 20 μL rxns (1 x 100 µL)
Order (95047-100)
500 x 20 μL rxns (1 x 500 µL)
Order (95047-500)
Product
Kit Size
Order Info
qScript XLT cDNA SuperMix
Request Sample
Kit Size:
Order Info:
25 x 20 μL rxns (1 x 100 µL)
Order (95161-025)
100 x 20 μL rxns (1 x 400 µL)
Order (95161-100)
500 x 20 μL rxns (2 x 1000 µL)
Order (95161-500)

Details

Contents
  • Extraction Reagent (1 x 25 mL or 2 x 125 mL)
  • Stabilization Buffer (1 x 25 mL or 2 x 125 mL)

Performance Data

Comparison of Extract Yield: Mouse Tails
Comparison of Extract Yield: Mouse Ears
Protocol Speed
Multiplex Genotyping

Resources

Flyers

Product Manuals

Technical Notes

CofA (PSFs)
Click here to see all CofA (PSFs)

SDSs

Publications

Plaque-associated human microglia accumulate lipid droplets in a chimeric model of Alzheimer’s disease
Christel Claes - 2021
Abstract
Background Disease-associated microglia (DAMs), that surround beta-amyloid plaques, represent a transcriptionally-distinct microglial profile in Alzheimer’s disease (AD). Activation of DAMs is dependent on triggering receptor expressed on myeloid cells 2 (TREM2) in mouse models and the AD TREM2-R47H risk variant reduces microglial activation and plaque association in human carriers. Interestingly, TREM2 has also been identified as a microglial lipid-sensor, and recent data indicates lipid droplet accumulation in aged microglia, that is in turn associated with a dysfunctional proinflammatory phenotype. However, whether lipid droplets (LDs) are present in human microglia in AD and how the R47H mutation affects this remains unknown. Methods To determine the impact of the TREM2 R47H mutation on human microglial function in vivo, we transplanted wild-type and isogenic TREM2-R47H iPSC-derived microglial progenitors into our recently developed chimeric Alzheimer mouse model. At 7 months of age scRNA-seq and histological analyses were performed. Results Here we report that the transcriptome of human wild-type TREM2 and isogenic TREM2-R47H DAM xenografted microglia (xMGs), isolated from chimeric AD mice, closely resembles that of human atherosclerotic foam cells. In addition, much like foam cells, plaque-bound xMGs are highly enriched in lipid droplets. Somewhat surprisingly and in contrast to a recent in vitro study, TREM2-R47H mutant xMGs exhibit an overall reduction in the accumulation of lipid droplets in vivo. Notably, TREM2-R47H xMGs also show overall reduced reactivity to plaques, including diminished plaque-proximity, reduced CD9 expression, and lower secretion of plaque-associated APOE. Conclusions Altogether, these results indicate lipid droplet accumulation occurs in human DAM xMGs in AD, but is reduced in TREM2-R47H DAM xMGs, as it occurs secondary to TREM2-mediated changes in plaque proximity and reactivity.
The entomological impact of passive metofluthrin emanators against indoor Aedes aegypti: A randomized field trial
Gregor J. Devine - 2021
Abstract
Background In the absence of vaccines or drugs, insecticides are the mainstay of Aedes-borne disease control. Their utility is challenged by the slow deployment of resources, poor community compliance and inadequate household coverage. Novel application methods are required. Methodology and principal findings A 10% w/w metofluthrin “emanator” that passively disseminates insecticide from an impregnated net was evaluated in a randomized trial of 200 houses in Mexico. The devices were introduced at a rate of 1 per room and replaced at 3-week intervals. During each of 7 consecutive deployment cycles, indoor resting mosquitoes were sampled using aspirator collections. Assessments of mosquito landing behaviours were made in a subset of houses. Pre-treatment, there were no differences in Aedes aegypti indices between houses recruited to the control and treatment arms. Immediately after metofluthrin deployment, the entomological indices between the trial arms diverged. Averaged across the trial, there were significant reductions in Abundance Rate Ratios for total Ae. aegypti, female abundance and females that contained blood meals (2.5, 2.4 and 2.3-times fewer mosquitoes respectively; P<0.001). Average efficacy was 60.2% for total adults, 58.3% for females, and 57.2% for blood-fed females. The emanators also reduced mosquito landings by 90% from 12.5 to 1.2 per 10-minute sampling period (P<0.05). Homozygous forms of the pyrethroid resistant kdr alleles V410L, V1016L and F1534C were common in the target mosquito population; found in 39%, 24% and 95% of mosquitoes collected during the trial. Conclusions/Significance This is the first randomized control trial to evaluate the entomological impact of any volatile pyrethroid on urban Ae. aegypti. It demonstrates that volatile pyrethroids can have a sustained impact on Ae. aegypti population densities and human-vector contact indoors. These effects occur despite the presence of pyrethroid-resistant alleles in the target population. Formulations like these may have considerable utility for public health vector control responses.
The relationship between insecticide resistance, mosquito age and malaria prevalence in Anopheles gambiae s.l. from Guinea
Emma Collins - 2019
Abstract
Insecticide resistance across sub-Saharan Africa may impact the continued effectiveness of malaria vector control. We investigated the association between carbamate and pyrethroid resistance with Anopheles gambiae s.l. parity, Plasmodium falciparum infection, and molecular insecticide resistance mechanisms in Guinea. Pyrethroid resistance was intense, with field populations surviving ten times the insecticidal concentration required to kill susceptible individuals. The L1014F kdr-N1575Y haplotype and I1527T mutation were significantly associated with mosquito survival following permethrin exposure (Prevalence Ratio; PR = 1.92, CI = 1.09–3.37 and PR = 2.80, CI = 1.03–7.64, respectively). Partial restoration of pyrethroid susceptibility following synergist pre-exposure suggests a role for mixed-function oxidases. Carbamate resistance was lower and significantly associated with the G119S Ace-1 mutation. Oocyst rates were 6.8% and 4.2% among resistant and susceptible mosquitoes, respectively; survivors of bendiocarb exposure were significantly more likely to be infected. Pyrethroid resistant mosquitoes had significantly lower parity rates than their susceptible counterparts (PR = 1.15, CI = 1.10–1.21). Our findings emphasize the need for additional studies directly assessing the influence of insecticide resistance on mosquito fitness.

Customer Testimonials

Extracta DNA Prep for PCR

"I needed to extract DNA from fungal tissue for one of our teaching labs. It worked amazing for further PCR reactions."

 

 

 

Andres P. | University Lab Coordinator
Extracta DNA Prep for PCR - Tissue

"Extracta DNA Prep for PCR  is one of the best, fastest and easiest to use reagent for genomic DNA isolation from human cells."

Scientist | Deutsches Krebsforschungszentrum (DKFZ)

Related Products

Product
Kit Size
Order Info
qScript cDNA SuperMix
Request Sample
Kit Size:
Order Info:
25 x 20 μL rxns (1 x 100 µL)
Order (95048-025)
100 x 20 μL rxns (1 x 400 µL)
Order (95048-100)
500 x 20 μL rxns (2 x 1000 µL)
Order (95048-500)
qScript cDNA Synthesis Kit
Request Sample
Kit Size:
Order Info:
25 x 20 μL rxns (1 x 25 µL)
Order (95047-025)
100 x 20 μL rxns (1 x 100 µL)
Order (95047-100)
500 x 20 μL rxns (1 x 500 µL)
Order (95047-500)
qScript XLT cDNA SuperMix
Request Sample
Kit Size:
Order Info:
25 x 20 μL rxns (1 x 100 µL)
Order (95161-025)
100 x 20 μL rxns (1 x 400 µL)
Order (95161-100)
500 x 20 μL rxns (2 x 1000 µL)
Order (95161-500)

Product Finder

Select Your Assay

Starting Template

Back

Assay Format

Back

Detection Chemistry

Back

Multiplexing (more than 3 targets)

Back

Is gene-specific priming (GSP) required?

Back

What current Reverse Transcriptase or cDNA kit are you using?

Back

Select the group which contains your real-time PCR cycler

  • Applied Biosystems 7500
  • Applied Biosystems 7500 Fast
  • Stratagene Mx3000P®
  • Stratagene Mx3005P™
  • Stratagene Mx4000™
  • Applied Biosystems ViiA 7
  • Applied Biosystems QuantStudio™
  • Agilent AriaMx
  • Douglas Scientific IntelliQube®
  • Applied Biosystems 5700
  • Applied Biosystems 7000
  • Applied Biosystems 7300
  • Applied Biosystems 7700
  • Applied Biosystems 7900
  • Applied Biosystems 7900HT
  • Applied Biosystems 7900 HT Fast
  • Applied Biosystems StepOne™
  • Applied Biosystems StepOnePlus™
  • Quantabio Q
  • BioRad CFX
  • Roche LightCycler 480
  • QIAGEN Rotor-Gene Q
  • Other
  • BioRad iCycler iQ™
  • BioRad MyiQ™
  • BioRad iQ™5
Back

Choose your application from the categories below

Back

Products

Back Next
I give Quantabio or an authorized Quantabio distributor permission to contact me for product updates and news.
* Required information
Back